Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subjects: Conference, Webcast

Moderna to Present at MIT Lecture Series


Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Stéphane Bancel, Chief Executive Officer will participate in the MIT Laboratory for Financial Engineering (LFE) and Golub Center for Finance and Policy (GCFP) Distinguished Lecture Series, "Dealing with Coronavirus: An Industry Perspective" on Wednesday, April 1 from 4:30-6:00 p.m. EDT.

To register for the webinar, a link will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com.

About Moderna

Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. mRNA medicines are designed to direct the body's cells to produce intracellular, membrane or secreted proteins that can have a therapeutic or preventive benefit and have the potential to address a broad spectrum of diseases. Moderna's platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing the Company the capability to pursue in parallel a robust pipeline of new development candidates. Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune and inflammatory diseases, independently and with strategic collaborators. Moderna has 24 mRNA development candidates in its portfolio across all modalities, with 12 in clinical studies. Four of these programs are in or preparing for Phase 2 studies and the Company is preparing for its first Phase 3 study.

Headquartered in Cambridge, Mass., Moderna currently has strategic alliances for development programs with AstraZeneca, Plc. (Nasdaq: AZN) and Merck, Inc. (Nasdaq: MRK), as well as the Defense Advanced Research Projects Agency (DARPA), an agency of the U.S. Department of Defense; the Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). Moderna has been named a top biopharmaceutical employer by Science for the past five years.


These press releases may also interest you

at 10:05
The "Distribution Deals in Diagnostics 2016 to 2024" report has been added to ResearchAndMarkets.com's offering. Distribution Deals in Diagnostics provides a detailed understanding and analysis of how and why companies enter distribution deals....

at 10:01
The Predictive Maintenance Market is estimated to grow from USD 10.6...

at 10:00
Frost & Sullivan recently researched the customer experience outsourcing services industry and, based on its findings, recognizes AeC with the 2023 Company of the Year Award. AeC is connecting technology with outstanding customer service to increase...

at 10:00
Bat Aroundtm announced its first MLB team partnership with the Tampa Bay Rays bringing the new game to Tropicana Field for the 2024 season. It's baseball meets video game. Hit the baseball and the computer animation plays out on the screen to gamify...

at 09:47
Gala Film, the leading decentralized streaming platform, announces the Global Premiere of its first-ever streaming series, RZR, on April 14, 2024. Starring and created by Award-winning actor and filmmaker David Bianchi (Queen of The South), "RZR"...

at 09:45
Truckin Digital, an innovator in logistics and transportation software solutions, is thrilled to unveil its 2024 Trucking Software ERP, a comprehensive suite designed to improve trucking operational capabilities. This latest release promises to...



News published on and distributed by: